Regular Article
A Novel Neurodevelopmental Syndrome Responsive to 5-Hydroxytryptophan and Carbidopa

https://doi.org/10.1006/mgme.2001.3187Get rights and content

Abstract

Tryptophan hydroxylase (TPH; EC 1.14.16.4) catalyzes the first rate-limiting step of serotonin biosynthesis by converting l-tryptophan to 5-hydroxytryptophan. Serotonin controls multiple vegetative functions and modulates sensory and alpha-motor neurons at the spinal level. We report on five boys with floppiness in infancy followed by motor delay, development of a hypotonic-ataxic syndrome, learning disability, and short attention span. Cerebrospinal fluid (CSF) analysis showed a 51 to 65% reduction of the serotonin end-metabolite 5-hydroxyindoleacetic acid (5HIAA) compared to age-matched median values. In one out of five patients a low CSF 5-methyltetrahydrofolate (MTHF) was present probably due to the common C677T heterozygous mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. Baseline 24-h urinary excretion showed diminished 5HIAA values, not changing after a single oral load with l-tryptophan (50–70 mg/kg), but normalizing after 5-hydroxytryptophan administration (1 mg/kg). Treatment with 5-hydroxytryptophan (4–6 mg/kg) and carbidopa (0.5–1.0 mg/kg) resulted in clinical amelioration and normalization of 5HIAA levels in CSF and urine. In the patient with additional MTHFR heterozygosity, a heterozygous missense mutation within exon 6 (G529A) of the TPH gene caused an exchange of valine by isoleucine at codon 177 (V177I). This has been interpreted as a rare DNA variant because the pedigree analysis did not provide any genotype-phenotype correlation. In the other four patients the TPH gene analysis was normal. In conclusion, this new neurodevelopmental syndrome responsive to treatment with 5-hydroxytryptophan and carbidopa might result from an overall reduced capacity of serotonin production due to a TPH gene regulatory defect, unknown factors inactivating the TPH enzyme, or selective loss of serotonergic neurons.

References (38)

  • N Blau et al.

    Disorders of tetrahydrobiopterin and related biogenic amines

  • K. Hyland

    Neurochemistry and defects of biogenic amine neurotransmitter metabolism

    J Inherit Metab Dis

    (1999)
  • D Peter et al.

    Differential, expression of two vesicular monoamine transporters

    J Neurosci

    (1995)
  • KP Lesch et al.

    Organisation of the human serotonin transporter gene

    J Neural Trans

    (1994)
  • ER Kandel

    Disorders of mood: Depression, mania, and anxiety disorders

  • LW Role et al.

    The brain stem: Cranial nerve nuclei and the monoaminergic systems

  • DC Chugani et al.

    Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children

    Ann Neurol

    (1999)
  • M Virkkunen et al.

    Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence

    J Psychiatry Neurosci

    (1995)
  • Cited by (0)

    1

    To whom correspondence should be addressed at Division of Paediatric Neurology, University Hospital Aachen, Pauwelsstrasse 30, D-52074 Aachen, Germany. Fax: ++49 241 8888481. E-mail: [email protected].

    View full text